Your browser doesn't support javascript.
loading
Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study.
Hu, Zili; Wang, Xiaohui; Fu, Yizhen; Yang, Dinghua; Zhou, Zhongguo; Chen, Minshan; Song, Xin; Zhang, Yaojun.
Afiliación
  • Hu Z; Department of Liver Surgery.
  • Wang X; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou.
  • Fu Y; Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University) Changsha.
  • Yang D; Department of Liver Surgery.
  • Zhou Z; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou.
  • Chen M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jishou University, Jishou, People's Republic of China.
  • Song X; Department of Liver Surgery.
  • Zhang Y; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou.
Int J Surg ; 110(2): 1019-1027, 2024 Feb 01.
Article en En | MEDLINE | ID: mdl-38006301

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Int J Surg Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Int J Surg Año: 2024 Tipo del documento: Article